InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by BOTHWELL IAN T, Chief Financial Officer. Officer active across 2 companies, notably Organicell Regenerative Medicine, Inc.. Cumulatively, 15 reports have been logged. Split: 0 buy · 12 sells. Total volume traded: €99k. Activity tracked since 3 May 2021. The latest transaction was disclosed on 14 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations15 total
175,000 shares0Common StockSEC:0001829126-26-000368:0
50 shares0Series C PreferredSEC:0001829126-24-008636:0
15,000,000 sharesCommon StockSEC:0001683168-21-005202:0
50,000 shares@ US$0.1383.1% of flowCommon StockSEC:0001683168-21-002663:0
50,000 shares@ US$0.143.1% of flowCommon StockSEC:0001683168-21-002587:0
50,000 shares@ US$0.1473.2% of flowCommon StockSEC:0001683168-21-002506:0
50,000 shares@ US$0.143.1% of flowCommon StockSEC:0001683168-21-002428:0
50,000 shares@ US$0.1924.2% of flowCommon StockSEC:0001683168-21-002362:0
40,000 shares@ US$0.1933.4% of flowCommon StockSEC:0001683168-21-002284:0
50,000 shares@ US$0.183.9% of flowCommon StockSEC:0001683168-21-002229:0
▼
50,000 shares@ US$0.224.8% of flowCommon StockSEC:0001683168-21-002143:0
▼
50,000 shares@ US$0.275.9% of flowCommon StockSEC:0001683168-21-002078:0
▼
50,000 shares@ US$0.2746.0% of flowCommon StockSEC:0001683168-21-001933:0
▼
50,000 shares@ US$0.3016.7% of flowCommon StockSEC:0001683168-21-001828:0
▼
50,000 shares@ US$0.255.5% of flowCommon StockSEC:0001683168-21-001788:0
15 of 15 declarations
About BOTHWELL IAN T
Ian T. Bothwell is the Chief Financial Officer of Organicell Regenerative Medicine, Inc.
